{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24933974",
  "DateCompleted": {
    "Year": "2014",
    "Month": "06",
    "Day": "30"
  },
  "DateRevised": {
    "Year": "2014",
    "Month": "06",
    "Day": "17"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "rus"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1682-8658",
      "JournalIssue": {
        "Issue": "11",
        "PubDate": {
          "Year": "2013"
        }
      },
      "Title": "Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology",
      "ISOAbbreviation": "Eksp Klin Gastroenterol"
    },
    "ArticleTitle": "[Reducing anxiety without deterioration of cognitive functions].",
    "Pagination": {
      "StartPage": "21",
      "EndPage": "25",
      "MedlinePgn": "21-5"
    },
    "Abstract": {
      "AbstractText": [
        "The purpose of the study--demonstrate the ability to reduce anxiety without having a negative impact on concentration and memory. In patients with irritable bowel syndrome studied anxiety, cognitive dysfunction, and memory. Patients received a standard basic therapy or standard treatment with psychotropic medication. Inclusion in the healing process valemidin significantly reduced anxiety in patients without a negative impact on cognitive function. IBS patients receiving basic therapy addition, valemidin, compared with the group of patients receiving only the basic therapy significantly decreased and cognitive dysfunction."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Reshetova",
        "ForeName": "T V",
        "Initials": "TV"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Zhigalova",
        "ForeName": "T N",
        "Initials": "TN"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Gazieva",
        "ForeName": "A A",
        "Initials": "AA"
      }
    ],
    "PublicationTypeList": [
      "Comparative Study",
      "English Abstract",
      "Journal Article",
      "Randomized Controlled Trial"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Russia (Federation)",
    "MedlineTA": "Eksp Klin Gastroenterol",
    "NlmUniqueID": "101144944",
    "ISSNLinking": "1682-8658"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Anti-Anxiety Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "administration & dosage"
      ],
      "DescriptorName": "Anti-Anxiety Agents"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "psychology"
      ],
      "DescriptorName": "Anxiety"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Cognition"
    },
    {
      "QualifierName": [
        "drug therapy",
        "etiology",
        "psychology"
      ],
      "DescriptorName": "Cognition Disorders"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy",
        "psychology"
      ],
      "DescriptorName": "Irritable Bowel Syndrome"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Male"
    },
    {
      "QualifierName": [
        "drug effects"
      ],
      "DescriptorName": "Memory"
    }
  ]
}